Skip to main content
. 2016 Dec 26;2016:baw143. doi: 10.1093/database/baw143

Table 3.

Overview of the number of annotated antimicrobials and combinations

Microorganism AMP combination with
Mode of growth
Experimental test
Combination type
AMP Anti(B/F) P B CKB and/or FIC/FBC T-K S Ad I A
P. aeruginosa 59 (8.97%) 489 (74.3%) 628 (95.4%) 18 (2.73%) 399 (60.7%) 85 (12.9%) 317 (48.2%) 118 (19.6%) 164 (24.9%) 48 (7.29%)
S. aureus 47 (10.2%) 280 (60.6%) 398 (86.2%) 40 (8.66%) 259 (56.1%) 44 (9.52%) 238 (51.5%) 127 (27.5%) 62 (13.4%) 35 (7.58%)
E. coli 53 (18.7%) 105 (37.1%) 268 (94.7%) 6 (2.12%) 152 (53.7%) 18 (6.36%) 102 (36.0%) 68 (24.0%) 71 (25.1%) 42 (14.9%)
L. monocytogenes 10 (17.9%) 0 47 (83.9%) 0 12 (21.4%) 0 38 (67.9%) 5 (8.93%) 13 (23.2%) 0
C. albicans 1 (1.03%) 51 (52.6%) 96 (99.0%) 0 55 (56.7%) 3 (3.09%) 54 (55.7%) 10 (10.3%) 11 (11.3%) 22 (22.7%)

Legend: Anti(B/F), antibiotic and antifungal; P, planktonic; B, biofilm; CKB, checkerboard; T-K, time-kill; S, synergic; Ad, additive; I, indifferent; A, antagonic.

Note: Synergic/additive plus additive/indifferent, and indifferent/antagonic combinations are included in the Ad and I categories, respectively. The percentages are relative to the total number of combinations for each microorganism.